Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
ImmunityBio Inc.

Start price
Target price
Perf. (%)
€7.90
29.04.24
€10.00
31.01.26
7.22%
03.05.24

Could be very worthwhile Investment >20% year
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€148.42
29.04.24
€168.07
29.04.25
2.53%
03.05.24

buy
Geron Corp.

Start price
Target price
Perf. (%)
€3.71
29.04.24
€9.34
29.04.25
-1.70%
03.05.24

buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.38
29.04.24
€20.55
29.04.25
-
20.03.24

buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.80
29.04.24
€100.00
29.04.25
2.41%
03.05.24

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€3.96
28.04.24
-
28.04.25
4.01%
03.05.24

buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.47
28.04.24
-
28.04.25
-
02.06.23

Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
28.04.24
-
28.04.25
-
15.07.23

buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€4.04
28.04.24
-
28.04.25
0.47%
26.04.24

buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.43
28.04.24
-
28.04.25
0.70%
02.05.24

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.83
28.04.24
-
28.04.25
5.85%
03.05.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.53
28.04.24
-
28.04.25
7.88%
03.05.24

Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
28.04.24
-
28.04.25
3.99%
03.05.24

Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
28.04.24
-
28.04.25
3.99%
03.05.24

Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
28.04.24
-
28.04.25
3.99%
03.05.24

Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.04
27.04.24
-
27.04.25
-1.41%
03.05.24

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.04
27.04.24
-
27.04.25
-1.41%
03.05.24

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€61.04
27.04.24
-
27.04.25
-1.41%
03.05.24

Lipocine Inc.

Start price
Target price
Perf. (%)
€3.67
27.04.24
-
27.04.25
-
09.02.24

Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.50
27.04.24
-
27.04.25
3.72%
03.05.24

Transgene S.A.

Start price
Target price
Perf. (%)
€1.17
27.04.24
€1.00
27.04.25
7.69%
02.05.24

buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€19.90
27.04.24
€20.00
27.04.25
24.62%
02.05.24

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€26.40
27.04.24
€30.00
27.04.25
18.94%
02.05.24

buy
Immunogen Inc.

Start price
Target price
Perf. (%)
€28.97
27.04.24
-
27.05.24
-
09.02.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
3.99%
03.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio